Screener
Regeneron Pharmaceuticals REGN Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Weighted average shares outstanding - diluted | 106.0 | 108.6 | 106.8 | 109.9 |
| Statements of Comprehensive Income | ||||
| Net income | $1,296.9 | $1,391.6 | $2,024.1 | $2,200.3 |
| Other comprehensive income (loss), net of tax: | ||||
| Unrealized (loss) gain on debt securities | (48.0) | 22.1 | (113.8) | 60.2 |
| Gain on foreign currency translation | 0.3 | 1.3 | 0.5 | 0.2 |
| Comprehensive income | $1,249.2 | $1,415.0 | $1,910.8 | $2,260.7 |
| The accompanying notes are an integral part of the financial statements. |
Item 1. Financial Statements (unaudited)
FAQ
- What is Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Regeneron Pharmaceuticals (REGN) reported comprehensive income (loss), net of tax, attributable to parent of $1.25B in Q2 2026.
- How has Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent decreased by 11.7% year-over-year, from $1.42B to $1.25B.
- What is the long-term trend for Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent has grown at a -13.0% compound annual growth rate (CAGR), from $8.02B to $4.59B.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Comprehensive income includes net income plus other items that are excluded from the income statement, such as unrealized gains or losses on securities and foreign currency translation adjustments. It provides a broader view of the change in equity from non-owner sources.
Ask your AI about Regeneron Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude